Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
Kiniksa Pharmaceuticals, Ltd. reports $12.3 million Q1 profit
By USInMinutes - May 02, 2023, 01:49 PM ET
Last Updated - Jul 18, 2023, 03:44 PM EDT
The company generated $48.30 million in quarterly revenue
Kiniksa Pharmaceuticals, Ltd. [KNSA] has reported fiscal Q1 profit of $12.30 million.
On a per-share basis, the D0 based company said its diluted earnings are $0.18.
The Pharmaceutical Preparations firm posted revenue of $48.30 million in this period.
Also Read:
- Kiniksa Pharmaceuticals to Report First Quarter 2023 Financial Results on May 2, 2023
- Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2022 Financial Results on ...
- Kiniksa Pharmaceuticals to Present at Bank of America Securities 2022 Biotech SMID Cap Conference
- Kiniksa Pharmaceuticals to Present at Evercore ISI 5th Annual HealthCONx Conference
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News